Latest StockRating News and Updates : StockRating updates, StockRating News , StockRating around the world

Nishadil

Washington | 20°C (light rain)

A Reality Check for Mattel? Goldman Sachs Downgrades Toy Giant

Top story

A Reality Check for Mattel? Goldman Sachs Downgrades Toy Giant

In focus

Latest feed

Wall Street's Bullish Bet on Hewlett Packard Enterprise

Etsy's Artisan Appeal: Why Analysts See Major Upside for the Unique Marketplace

The Drumbeat Builds: Milestone Pharma Prepares for Q4 Earnings Reveal

Quantum Leap? Why IonQ Stock Just Soared on a Major Analyst Upgrade Today

Latest headlines

CAVA Group: Why One Analyst Sees Major Outperformance Ahead

CAVA Group: Why One Analyst Sees Major Outperformance Ahead

Marvell's AI Play Gets a Big Thumbs Up

Marvell's AI Play Gets a Big Thumbs Up

Navigating the High Seas of Investment: A Closer Look at Tidewater's Trajectory

Navigating the High Seas of Investment: A Closer Look at Tidewater's Trajectory

The Shifting Sands: JPMorgan Chimes In on Treace Medical, and It's a Sobering Note

The Shifting Sands: JPMorgan Chimes In on Treace Medical, and It's a Sobering Note

Amidst Market Churn: The Enduring Stability of Cold Storage and Americold's Steady Outlook

Amidst Market Churn: The Enduring Stability of Cold Storage and Americold's Steady Outlook

A Whisper of Change: Decoding Wall Street's Latest Take on OFS Capital

A Whisper of Change: Decoding Wall Street's Latest Take on OFS Capital

The Shifting Sands of Biotech: Wall Street Zen Taps Puma Biotech's Roar Down a Notch

The Shifting Sands of Biotech: Wall Street Zen Taps Puma Biotech's Roar Down a Notch

A Second Look? Wall Street Zen Shifts Stance on ECARX, Moving to a 'Hold'

A Second Look? Wall Street Zen Shifts Stance on ECARX, Moving to a 'Hold'

The Biotech Beat: Why Wall Street's Whispers Are Turning to Crinetics

The Biotech Beat: Why Wall Street's Whispers Are Turning to Crinetics

The Steady Hand: Why Fiserv's 'Neutral' Rating Isn't Budging

The Steady Hand: Why Fiserv's 'Neutral' Rating Isn't Budging

From Hold to High Hopes: Why Wall Street Just Elevated Tokio Marine's Status

From Hold to High Hopes: Why Wall Street Just Elevated Tokio Marine's Status

Zen Technologies' Ascent: Why the Market is Watching, But Motilal Oswal Holds a 'Neutral' Card

Zen Technologies' Ascent: Why the Market is Watching, But Motilal Oswal Holds a 'Neutral' Card

Amara Raja Soars: Nuvama Reaffirms 'Buy' on New Energy Vision Post CFO Meeting

Amara Raja Soars: Nuvama Reaffirms 'Buy' on New Energy Vision Post CFO Meeting

Aditya Birla Fashion & Retail: A Nuanced Look at Motilal Oswal's 'Neutral' Stance and Rs 100 Target

Aditya Birla Fashion & Retail: A Nuanced Look at Motilal Oswal's 'Neutral' Stance and Rs 100 Target

American Express Platinum: Navigating Fatigue for Future Growth

American Express Platinum: Navigating Fatigue for Future Growth

Micron Soars: AI Revolution Propels Stock to New Heights, Analyst Sees Massive Upside

Micron Soars: AI Revolution Propels Stock to New Heights, Analyst Sees Massive Upside

Guggenheim Casts a 'Neutral' Eye on Immunocore's Future as Kimmtrak's Path Unfolds

Guggenheim Casts a 'Neutral' Eye on Immunocore's Future as Kimmtrak's Path Unfolds

Bank of America Reaffirms 'Buy' on Dell: Smooth CFO Transition Signals Continued Confidence in AI-Driven Growth

Bank of America Reaffirms 'Buy' on Dell: Smooth CFO Transition Signals Continued Confidence in AI-Driven Growth

TransMedics: Stifel Initiates 'Hold' Amidst Innovation, Citing Valuation Concerns

TransMedics: Stifel Initiates 'Hold' Amidst Innovation, Citing Valuation Concerns

IDEAYA Biosciences Ignites Investor Excitement with Dual "Buy" Ratings from Barclays and Citizens

IDEAYA Biosciences Ignites Investor Excitement with Dual "Buy" Ratings from Barclays and Citizens

Wells Fargo Crowns Axsome Therapeutics a Biotech Heavyweight with 'Overweight' Rating on Blockbuster Alzheimer's Potential

Wells Fargo Crowns Axsome Therapeutics a Biotech Heavyweight with 'Overweight' Rating on Blockbuster Alzheimer's Potential

Amara Raja Batteries: Why Motilal Oswal Maintains a Neutral Stance Amidst Evolving Market Dynamics

Amara Raja Batteries: Why Motilal Oswal Maintains a Neutral Stance Amidst Evolving Market Dynamics

NTPC's Power Play: Motilal Oswal Maintains 'Neutral' Stance with Rs 380 Target

NTPC's Power Play: Motilal Oswal Maintains 'Neutral' Stance with Rs 380 Target

Piper Sandler Initiates Bullish Coverage on Monday.com, Eyes Significant Upside

Piper Sandler Initiates Bullish Coverage on Monday.com, Eyes Significant Upside

Load more